$NHHS
NorthStar Healthcare Income, Inc.

2023 Q3 Form 10-Q Financial Statement

#000150370723000025 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $53.37M $51.50M
YoY Change 11.8% 13.51%
Cost Of Revenue $36.89M $35.03M
YoY Change 5.0% 5.4%
Gross Profit $16.48M $16.48M
YoY Change 30.77% 35.68%
Gross Profit Margin 30.88% 31.99%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.848M $9.808M
YoY Change 2.14% 2.81%
% of Gross Profit 59.74% 59.53%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $14.25M $11.53M
YoY Change 29.38% 9.29%
% of Operating Profit
Other Income/Expense, Net $0.00 $70.00K
YoY Change 1300.0%
Pretax Income -$11.24M -$56.46M
YoY Change -65.28% 105.96%
Income Tax $17.00K $11.00K
% Of Pretax Income
Net Earnings -$11.38M -$59.01M
YoY Change -61.43% -990.51%
Net Earnings / Revenue -21.33% -114.58%
Basic Earnings Per Share -$0.06 -$0.30
Diluted Earnings Per Share -$0.06 -$0.30
COMMON SHARES
Basic Shares Outstanding 185.7M shares 195.4M shares
Diluted Shares Outstanding 185.7M shares 193.2M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $87.58M $107.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $2.000M $2.085M
YoY Change -14.42% -13.88%
Long-Term Investments $128.0M $128.2M
YoY Change -37.61% -38.4%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.136B $1.146B
YoY Change -9.79% -11.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $928.5M $927.3M
YoY Change -1.45% -1.85%
SHAREHOLDERS EQUITY
Retained Earnings -$1.512B -$1.501B
YoY Change 7.19% 8.67%
Common Stock $1.719B $1.718B
YoY Change -0.68% -0.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $206.8M $217.6M
YoY Change
Total Liabilities & Shareholders Equity $1.136B $1.146B
YoY Change -9.79% -11.23%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$11.38M -$59.01M
YoY Change -61.43% -990.51%
Depreciation, Depletion And Amortization $9.848M $9.808M
YoY Change 2.14% 2.81%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#RealEstateInvestmentPropertyNet
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#RealEstateInvestmentPropertyNet
CY2022Q2 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q2 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilities
us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2022Q2 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GainLossOnInvestments
us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2023Q2 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GainLossOnInvestments
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-57781000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-57781000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-71707000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
193156094 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
193708466 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
193708466 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
301072000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
45000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
22000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1248000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-13997000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
288346000 usd
CY2023Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
55000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
33000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
13399000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
844000 usd
CY2023Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3275000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-59014000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
218386000 usd
us-gaap Profit Loss
ProfitLoss
-73011000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6468000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
36555000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19457000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19463000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
43422000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
13002000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1653000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1614000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
314000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
312000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
114000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
93000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-4315000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
335000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
193000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
186000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
5104000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
10640000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1004000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
277000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1013000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3838000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-186000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-3432000 usd
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
-260000 usd
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
-58000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3822000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8735000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-55000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
32000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11259000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12102000 usd
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
11090000 usd
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
10660000 usd
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
135000 usd
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
0 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
13472000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
38140000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3040000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
9500000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
12012000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
63000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
272000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1279000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
97018000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
100000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
177000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
55000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
114000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10797000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-109239000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3502000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-93861000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115660000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
210938000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119162000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117077000 usd
us-gaap Interest Paid Net
InterestPaidNet
20933000 usd
us-gaap Interest Paid Net
InterestPaidNet
18725000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
47000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
23000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2550000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1047000 usd
CY2023Q2 us-gaap Distribution Payable
DistributionPayable
0 usd
CY2022Q2 us-gaap Distribution Payable
DistributionPayable
34000 usd
us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
13399000 usd
us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
25000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Nature Of Operations
NatureOfOperations
Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), owns a diversified portfolio of seniors housing properties, including independent living facilities (“ILF”), assisted living (“ALF”) and memory care facilities (“MCF”) located throughout the United States. In addition, the Company also has investments through non-controlling interests in joint ventures in a broader spectrum of healthcare real estate, including seniors housing properties, as well as skilled nursing (“SNF”) and ancillary services businesses, located throughout the United States.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company has conducted its operations, and intends to do so in the future, so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), which became indirect subsidiaries of the Company on June 9, 2023. NorthStar Healthcare Income Advisor, LLC invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which were collectively recorded as non-controlling interests on the accompanying consolidated balance sheets prior to June 9, 2023. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of June 30, 2023, the Company’s limited partnership interest in the Operating Partnership, directly or indirectly, was 100.0%.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company raised $2.0 billion in total gross proceeds from the sale of shares of common stock in its continuous, public offerings (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Internalization</span></div>From inception through October 21, 2022, the Company was externally managed by CNI NSHC Advisors, LLC or its predecessor (the “Former Advisor”), an affiliate of NRF Holdco, LLC (the “Former Sponsor”). The Former Advisor was responsible for managing the Company’s operations, subject to the supervision of the Company’s board of directors, pursuant to an advisory agreement. On October 21, 2022, the Company completed the internalization of the Company’s management function (the “Internalization”). In connection with the Internalization, the Company agreed with the Former Advisor to terminate the advisory agreement and arranged for the Former Advisor to continue to provide certain services for a transition period.
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000000000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
128200000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
9500000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of the COVID-19 pandemic, inflation, rising interest rates, risk of recession and other economic conditions as reflected and/or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q. Such estimates may change and the impact of which could be material.</span></div>
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107306000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103926000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
11856000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
11734000 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
500000 usd
nshi Finance Lease Payments
FinanceLeasePayments
100000 usd
nshi Finance Lease Payments
FinanceLeasePayments
300000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
47000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
69000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
38000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
33000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
18000 usd
CY2023Q2 nshi Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
10000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
215000 usd
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
31000 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
184000 usd
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.069
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-200000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
300000 usd
CY2023Q2 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 day
CY2023Q2 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 day
CY2023Q2 us-gaap Proceeds From Rents Received
ProceedsFromRentsReceived
300000 usd
us-gaap Proceeds From Rents Received
ProceedsFromRentsReceived
300000 usd
CY2023Q2 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
3600000 usd
CY2023Q2 nshi Number Of Triple Net Lease Portfolios
NumberOfTripleNetLeasePortfolios
4 property
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
118064000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
117896000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2085000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2253000 usd
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
100000 usd
CY2023Q2 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
100000 usd
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
200000 usd
CY2022Q2 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
200000 usd
CY2023Q2 nshi Deferred Costsand Finite Lived Intangible Assets Amortization Expense Remainderof Fiscal Year
DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseRemainderofFiscalYear
169000 usd
CY2023Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne
337000 usd
CY2023Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
337000 usd
CY2023Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree
337000 usd
CY2023Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFour
337000 usd
CY2023Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense After Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
568000 usd
CY2023Q2 nshi Deferred Costsand Finite Lived Intangible Assets Net
DeferredCostsandFiniteLivedIntangibleAssetsNet
2085000 usd
CY2022Q2 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
5500000 usd
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
7100000 usd
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
7100000 usd
us-gaap Depreciation
Depreciation
19300000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
38700000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
13000000 usd
nshi Number Of Facilities Impaired
NumberOfFacilitiesImpaired
5 facility
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
11400000 usd
CY2023Q2 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
11400000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15600000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1196553000 usd
CY2023Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
282792000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
263551000 usd
CY2023Q2 us-gaap Real Estate Investments
RealEstateInvestments
888684000 usd
CY2022Q4 us-gaap Real Estate Investments
RealEstateInvestments
933002000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
9700000 usd
us-gaap Depreciation
Depreciation
19300000 usd
CY2023Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3300000 usd
CY2023Q2 us-gaap Land
Land
121424000 usd
CY2022Q4 us-gaap Land
Land
121518000 usd
CY2023Q2 us-gaap Land Improvements
LandImprovements
19459000 usd
CY2022Q4 us-gaap Land Improvements
LandImprovements
18945000 usd
CY2023Q2 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
929810000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
957924000 usd
CY2023Q2 us-gaap Tenant Improvements
TenantImprovements
372000 usd
CY2022Q4 us-gaap Tenant Improvements
TenantImprovements
372000 usd
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2411000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
6736000 usd
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
98000000 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
91058000 usd
CY2023Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1171476000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
128153000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
176502000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2546000 usd
CY2023Q2 nshi Proceeds From Equity Method Investment Distribution Operating And Investing Activities
ProceedsFromEquityMethodInvestmentDistributionOperatingAndInvestingActivities
21778000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34053000 usd
CY2022Q2 nshi Proceeds From Equity Method Investment Distribution Operating And Investing Activities
ProceedsFromEquityMethodInvestmentDistributionOperatingAndInvestingActivities
31087000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6468000 usd
nshi Proceeds From Equity Method Investment Distribution Operating And Investing Activities
ProceedsFromEquityMethodInvestmentDistributionOperatingAndInvestingActivities
24112000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
36555000 usd
nshi Proceeds From Equity Method Investment Distribution Operating And Investing Activities
ProceedsFromEquityMethodInvestmentDistributionOperatingAndInvestingActivities
38140000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
11400000 usd
CY2023Q2 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
11400000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
20754000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
19612000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
669466000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
46876000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
156145000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
912853000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45667 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
113750 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93167 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
352500 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
211250 usd
CY2022Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2022Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
97000000 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
226500000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
9700000 shares
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1200000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1300000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-200000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-200000 usd
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
1000000 usd
CY2023Q2 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
51503000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35026000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
11534000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3593000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9808000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
43422000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
70000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-4647000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2546000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-59014000 usd
CY2022Q2 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
45374000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33230000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
10554000 usd
CY2022Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2457000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3755000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9540000 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
13002000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-252000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34053000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
6627000 usd
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
101071000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
70103000 usd
us-gaap Interest Expense
InterestExpense
22893000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
97000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7503000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19457000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
43422000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
202000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-4315000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6468000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 usd
us-gaap Profit Loss
ProfitLoss
-73011000 usd
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
88706000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
66124000 usd
us-gaap Interest Expense
InterestExpense
20863000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
5104000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7441000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19463000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
13002000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
335000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
36555000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
us-gaap Profit Loss
ProfitLoss
-6354000 usd
CY2023Q2 us-gaap Assets
Assets
1145640000 usd
CY2022Q4 us-gaap Assets
Assets
1237835000 usd
CY2023Q2 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
56 property
CY2023Q2 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
6817 unit
us-gaap Noninterest Income
NoninterestIncome
101071000 usd
CY2023Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
600000 usd
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001503707-23-000025-index-headers.html Edgar Link pending
0001503707-23-000025-index.html Edgar Link pending
0001503707-23-000025.txt Edgar Link pending
0001503707-23-000025-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nshi-20230630.htm Edgar Link pending
nshi-20230630.xsd Edgar Link pending
nshi-20230630_g1.jpg Edgar Link pending
nshi-20230630_g2.jpg Edgar Link pending
nshi06302023exhibit311.htm Edgar Link pending
nshi06302023exhibit312.htm Edgar Link pending
nshi06302023exhibit321.htm Edgar Link pending
nshi06302023exhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nshi-20230630_cal.xml Edgar Link unprocessable
nshi-20230630_def.xml Edgar Link unprocessable
nshi-20230630_lab.xml Edgar Link unprocessable
nshi-20230630_pre.xml Edgar Link unprocessable
nshi-20230630_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending